Roelof Rongen - Net Worth and Insider Trading

Roelof Rongen Net Worth

The estimated net worth of Roelof Rongen is at least $644,174 dollars as of 2024-04-26. Roelof Rongen is the CEO of Matinas BioPharma Holdings Inc and owns about 3,539,416 shares of Matinas BioPharma Holdings Inc (MTNB) stock worth over $644,174. Details can be seen in Roelof Rongen's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Roelof Rongen has not made any transactions after 2017-09-08 and currently still holds the listed stock(s).

Transaction Summary of Roelof Rongen

To

Roelof Rongen Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Roelof Rongen owns 2 companies in total, including Matinas BioPharma Holdings Inc (MTNB) , and GRI Bio Inc (GRI) .

Click here to see the complete history of Roelof Rongen’s form 4 insider trades.

Insider Ownership Summary of Roelof Rongen

Ticker Comapny Transaction Date Type of Owner
MTNB Matinas BioPharma Holdings Inc 2017-09-08 director & Chief Executive Officer
GRI GRI Bio Inc 2023-04-21 director

Roelof Rongen Latest Holdings Summary

Roelof Rongen currently owns a total of 1 stock. Roelof Rongen owns 3,539,416 shares of Matinas BioPharma Holdings Inc (MTNB) as of September 8, 2017, with a value of $644,174.

Latest Holdings of Roelof Rongen

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MTNB Matinas BioPharma Holdings Inc 2017-09-08 3,539,416 0.18 644,174

Holding Weightings of Roelof Rongen


Roelof Rongen Form 4 Trading Tracker

According to the SEC Form 4 filings, Roelof Rongen has made a total of 0 transactions in Matinas BioPharma Holdings Inc (MTNB) over the past 5 years. The most-recent trade in Matinas BioPharma Holdings Inc is the acquisition of 5,000 shares on September 8, 2017, which cost Roelof Rongen around $6,800.

Insider Trading History of Roelof Rongen

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Roelof Rongen Trading Performance

GuruFocus tracks the stock performance after each of Roelof Rongen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Roelof Rongen is 11.11%. GuruFocus also compares Roelof Rongen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Roelof Rongen within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Roelof Rongen's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Roelof Rongen Ownership Network

Ownership Network List of Roelof Rongen

No Data

Ownership Network Relation of Roelof Rongen


Roelof Rongen Owned Company Details

What does Matinas BioPharma Holdings Inc do?

Who are the key executives at Matinas BioPharma Holdings Inc?

Roelof Rongen is the director & Chief Executive Officer of Matinas BioPharma Holdings Inc. Other key executives at Matinas BioPharma Holdings Inc include Chief Technology Officer Liu Hui , Chief Business Officer Thomas Hoover , and director & Chief Executive Officer Jerome D Jabbour .

Matinas BioPharma Holdings Inc (MTNB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Matinas BioPharma Holdings Inc (MTNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Matinas BioPharma Holdings Inc (MTNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Matinas BioPharma Holdings Inc (MTNB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Matinas BioPharma Holdings Inc Insider Transactions

No Available Data

Roelof Rongen Mailing Address

Above is the net worth, insider trading, and ownership report for Roelof Rongen. You might contact Roelof Rongen via mailing address: C/o Matinas Biopharma Holdings, Inc., 1545 Route 206 South, Suite 302, Bedminster Nj 07921.

Discussions on Roelof Rongen

No discussions yet.